Featured Videos & Interviews
Cancer Genetics Appoints Mandar Kulkarni, Ph.D., as Chief Technology Officer of Cancer Genetics...Lattice Announces First Quarter 2015 Financial Results...Giggles N' Hugs Announces First Quarter Revenue Up 11.7% year over year...Legacy Education Announces First Quarter 2015 Earnings...OxySure (OXYS) to Host First Quarter 2015 Financial Results Conference Call at 4:15 pm ET on Ma...OPKO Announces 4Kscore® Abstracts at the 2015 American Urological Association (AUA) Annual...Calpian, Inc. Upgrades to OTCQX Marketplace...CUR Media, Inc. - "One Year Later: Where We Are Now"...Vapir Announces the Prima Portable Vaporizer...Akers Biosciences Introduces New Rapid Breath Ketone and Oxidative Stress Tests to the Health a...
"RedChip has been instrumental in raising our profile among both savvy institutional investors and retail investors that are looking for differentiated and unique companies. RedChip has developed a unique combination of providing targeted media exposure and investor relations support for emerging companies."
Panna Sharma, CEO of Cancer Genetics, Inc. (NasdaqCM: CGIX)
"I have appeared on the RedChip Money Report TV show four times. Dave Gentry, the host, is professional and engaging. I strongly recommend this show for CEOs who want exposure to thousands of microcap investors. There is a very tangible benefit of appearing on RedChip's 'Small Stocks, Big Money."
Jim Czirr, CEO of Galectin Therapeutics, Inc.
"I value our relationship with RedChip. I have nothing but praise for the RedChip team. Their platform is innovative and effective. I strongly recommend them for any serious smaller-cap company that needs exposure to Wall Street's institutional and retail investor community."
Semyon Dukach, Chairman SMTP INC
"Whether delivered over Skype or live from the Orlando studios or during a conference -- RedChip has helped increase awareness of Lightbridge's prospects as a developer of next-generation nuclear fuel technology and global advisory services. Moreover, we have been impressed by Dave Gentry's thorough grasp of our business model and his effective communication of our strategic goals.""
Seth Grae, President and CEO of Lightbridge Corp.
"I appreciate the RedChip team. They were the first investor relations firm to truly understand our story and position us properly to micro-cap investors. They seem to know all the small-cap investment banks, family offices and fund-managers that buy smaller companies. Their media platform is the best I have ever seen for companies with market caps of $500 million and under. I recommend them highly.""
DHRU Desai, Chairman-Quadrant 4 Systems
"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is discovering tomorrow's blue chips today."
Bob McCooey, Senior Vice President The NASDAQ Stock Market
"I am very pleased with RedChip. Their ability to generate quality one-on-one meetings with small-cap funds and retail brokers is impressive, particularly when matched with their research report and conference platform. I would strongly recommend them to any small-cap company listed or bulletin board who needs professional and systematic investor relations services."
Frank Jaksch, Co-Chairman/Founder and CSO, ChromaDex Corporation
- Akers Biosciences Presenting at US Investor Conference
- American Water Announces Recipients of James LaFrankie Scholarship Awards
- SeeThruEquity Issues Company Update Note on Calpian, Inc. (OTCQX: CLPI) Increasing Price Target to $2.76
- Energy Fuels to Acquire Key Mineral Properties Adjacent to Its Roca Honda Uranium Project in New Mexico
- Galectin Therapeutics to Present at LD Micro Invitational Conference
Top CEO Interviews, Commercials and Blogs
Dave Gentry Signs Book Contract with Wiley Publishing
Wiley to publish “Microcap Superstars” in Hardback and Digital. Read More
Why Investors Could Triple Their Investment on this Microcap Stock
It’s not often we see an OTC Markets microcap stock with $96.5 million in revenue and $7.4 million in net income.Read More
Acquisition in Professional Education Space by LinkedIn Bodes Well for Other Professional Education Companies: Lynda.com Purchased for $1.5 Billion
New to the Public Markets, (OTCQB: LEAI) Legacy Education Alliance Has Strong Fundamentals and Big Growth: $96.5 Million Revenue, $0.45 EPS FY 2014, Low PE.Read More
Why the Founder of MTV and Former RCA CEO Teamed Up on CUR Media
While the market for streaming music came in at only $1 billion of the $7 billion U.S. recorded music industry in 2012, experts forecast that 70% of revenue in the digital music space will come from streaming and subscription services by 2019.Read More
Dave Gentry's Top 3 OTC Tech Stocks Set for Up Listing in 2015
As we enter our 23rd year of “Discovering Tomorrow’s Blue Chips Today,” we’d like to bring your attention to three over-the-counter (OTC) tech stocks that are set for up listing and significant gains in 2015.Read More
Dave Gentry Interviews Royce Funds' Bill Hench- RedChip Global Online CEO Conference
RedChip Money Report’s Dave Gentry talks with Royce Funds’ Bill Hench in this exclusive RedChip TV interview. Hench is portfolio manager of Royce Funds’ small-cap Opportunity Fund and Opportunity Select Fund." Watch Now
AVG A Leader in Online Security
Host Dave Gentry interviews John Little, CFO of AVG Technologies (NYSE:), The company offers various consumer suites for core protection, including anti-virus, anti-spyware, anti-rootkit, social networking protection, and LinkScanner.Watch Now
NetGear Global Leader in Internet Connectivity
Host Dave Gentry interviews Christine Gorjanc, Chief Financial Officer of NETGEAR, Inc (Nasdaq: NTGR), networking products for consumers, businesses, and service providers. The company operates in three segments: Retail, Commercial, and Service Provider. Watch Now
Opexa (OPXA) Developing MS Treatment in Partnership with Merck Serono
Host Dave Gentry interviews Neil Warma, CEO of Opexa Therapeutics (Nasdaq: OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), on "The RedChip Money Report: Small Stocks Big Money."Watch Now
Actinium Pharmeceuticals, Inc. (NYSE: ATNM)
A bio pharmaceutical company developing innovative targeted payload immuno-therapeutics for the treatment of advanced cancers. Watch Now
Quadrant 4 Systems, (QFOR): Emerging Growth Healthcare Exchange Platform
QFOR’s healthcare exchange platform (QHIX) projected to reach a yearly run rate of $48 million in revenue by end of 2014. Healthcare exchanges projected as a $2B-$6B market.Watch Now
Drone Aviation Corp. (DRNE): Cutting-Edge Drone Monitoring and Communication Technology
DRN's mission is to aggressively penetrate the expanding Drone market with our unique Tethered Drones, which are currently being fielded to the U.S. Department of Defense and State and Local municipalities. Watch Now
Akers Biosciences (NASDAQCM: AKER)
Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. Watch Now
(Nasdaq: TOPS) Top Ships, Inc: Money Report Interview - October 7, 2014 (Fox Business)
Host Dave Gentry interviews Alexandros Tsirikos, Chief Financial Officer of Top Ships, Inc (Nasdaq: TOPS), this company provides international seaborne transportation services carrying petroleum products and crude oil for the oil industry; and drybulk commodities for the steel, electric utility, construction, and agriculture-food industries. Watch Now
American Water Works (AWK): The Largest Publicly Traded U.S Water and Wastewater Utility Company
Host Dave Gentry interviews Edward Vallejo, Director of Investor Relations at American Water Works (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company on "The RedChip Money Report: Small Stocks Big Money." Watch Now